In contrast, it is likely that PGE2 treatment was able to restore the binding of Foxo3a to active β-catenin in Lgr4Gt/Gt CML stem cells because these cells suffer only from a decrease in Lgr4 mRNA expression. Here, FOXO3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.